Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GZR18 injection for weight loss extension study
NCT07292441Phase 3Recruiting
- Sponsor
- Gan & Lee Pharmaceuticals
- Start
- Jan 2026
- Primary completion
- Sep 2027
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 3 trial of bofanglutide in obesity, sponsored by Gan & Lee Pharmaceuticals. Started Jan 2026; status: recruiting.
02
Drugs
bofanglutide
03
Conditions
obesity
Beyond the preview
Go deeper on NCT07292441.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07292441.